Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Milwaukee. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Milwaukee location
Access multiple myeloma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
Check if you qualify for this multiple myeloma clinical trial in Milwaukee, WI
No-Cost Study Care
Local to Milwaukee
Convenient for WI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is an open-label, multi-site, Phase II randomized trial with response-adaptive design for newly diagnosed multiple myeloma (NDMM) participants who have had prior induction therapy. The primary objective of this study is to compare the rates of achieving undetectable measurable residual disease (MRD) in the bone marrow with elranatamab and daratumumab employed as post-induction consolidation and maintenance treatment (Arm A) versus autologous stem cell transplant (ASCT) followed by lenalidom
Sponsor: SCRI Development Innovations, LLC
Yes, this clinical trial (NCT06974786) has an active research site in Milwaukee, WI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for multiple myeloma treatment options in Milwaukee, WI, this clinical trial (NCT06974786) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Milwaukee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all multiple myeloma clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Milwaukee — not just this study.
Browse Multiple Myeloma Trials in Milwaukee →